| Literature DB >> 18638370 |
Emmanuel E Douzinas1, Ilias Andrianakis, Olga Livaditi, Pantelis Paneris, Marios Tasoulis, Aimilia Pelekanou, Alex Betrosian, Evangelos J Giamarellos-Bourboulis.
Abstract
BACKGROUND: To evaluate whether the level of hypotension during hemorrhagic shock may influence the oxidative and inflammatory responses developed during post-ischemic resuscitation.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18638370 PMCID: PMC2483989 DOI: 10.1186/1472-6793-8-15
Source DB: PubMed Journal: BMC Physiol ISSN: 1472-6793
Serum biochemical parameters.
| Group sham | Group shock-40 | Group shock-30 | |
| AST (Mean ± SD, U/L) | |||
| Baseline | 18.0 ± 1.9 | 25.0 ± 9.7a | 21.7 ± 9.3c, e |
| End of shock | 20.4 ± 2.2 | 25.4 ± 8.9a | 29.3 ± 7.2c, e |
| 30 min | 20.8 ± 3.1 | 29.0 ± 8.4a | 37.0 ± 5.0c, e |
| 60 min | 24.0 ± 1.6 | 32.6 ± 9.1a | 44.0 ± 2.6c, f |
| 90 min | 23.4 ± 3.2 | 39.0 ± 13.9b | 54.7 ± 6.0d, e |
| 120 min | 24.6 ± 2.7 | 45.8 ± 15.4b | 61.0 ± 6.6d, f |
| ALT (Mean ± SD, U/L) | |||
| Baseline | 17.6 ± 3.2 | 20.2 ± 7.4a | 17.7 ± 4.2c, e |
| End of shock | 19.6 ± 3.6 | 23.4 ± 7.5a | 20.3 ± 8.5c, e |
| 30 min | 18.4 ± 2.5 | 25.0 ± 7.2a | 23.0 ± 8.5c, e |
| 60 min | 18.8 ± 2.6 | 28.4 ± 8.3a | 24.3 ± 8.1c, e |
| 90 min | 18.2 ± 1.6 | 31.0 ± 8.9a | 24.6 ± 8.1c, e |
| 120 min | 19.4 ± 1.5 | 34.4 ± 8.5b | 31.7 ± 8.1c, e |
| Creatinine (Mean ± SD, mg/dl) | |||
| Baseline | 1.10 ± 0.42 | 0.90 ± 0.07a | 1.10 ± 0.20c, e |
| End of shock | 1.08 ± 0.38 | 0.96 ± 0.15a | 1.33 ± 0.32c, e |
| 30 min | 1.04 ± 0.34 | 1.02 ± 0.08a | 1.27 ± 0.40c, e |
| 60 min | 0.94 ± 0.21 | 1.08 ± 0.13a | 1.37 ± 0.35c, e |
| 90 min | 0.88 ± 0.28 | 1.08 ± 0.22a | 1.50 ± 0.36d, e |
| 120 min | 0.90 ± 0.29 | 1.22 ± 0.32a | 1.63 ± 0.46d, f |
Serum concentrations of aspartate aminotransferase (AST), alanine aminotransferase (AST) and creatinine of animals undergoing sham operation (group sham); animals undergoing hemorrhagic shock to MAP 40 mmHg (group shock-40) before start of resuscitation; and animals undergoing hemorrhagic shock to MAP 30 mmHg (group shock-30) before start of resuscitation.
Statistical comparisons after Bonferroni correction
Group sham vs group shock-40: apNS (non-significant); bp < 0.05
Group sham vs group shock-30: cpNS (non-significant); dp < 0.05
Group shock-40 vs group shock-30: epNS (non-significant); fp < 0.05
Figure 1Cytokines levels in all study groups. Concentrations of interleukin (IL)-1β (left panel), tumor necrosis factor-alpha (TNF-α) (middle panel) and IL-6 (right panel) in serum of animals undergoing sham operation (group sham); animals undergoing hemorrhagic shock to MAP 40 mmHg (group shock-40); and animals undergoing hemorrhagic shock to MAP 30 mmHg (group shock-30). P values refer to comparisons between group shock-40 and group shock-30 at the respective time interval.
Figure 2Oxidative burst in all study groups. Oxidative burst of polymorphonuclears (PMNs) and mononuclear cells (MCs) of animals undergoing sham operation (group sham); animals undergoing hemorrhagic shock to MAP 40 mmHg (group shock-40); and animals undergoing hemorrhagic shock to MAP 30 mmHg (group shock-30). GMFI, geometric mean of the fluorescence intensity.
Serum oxidative parameters and endotoxin.
| Group sham | Group shock-40 | Group shock-30 | |
| MDA (Mean ± SD, μmol/mL) | |||
| Baseline | 0.61 ± 0.16 | 0.81 ± 0.15a | 0.69 ± 0.07c, e |
| End of shock | 0.88 ± 0.09 | 1.77 ± 0.09b | 1.69 ± 0.04d, e |
| 30 min | 1.04 ± 0.27 | 2.32 ± 0.12b | 2.16 ± 0.08d, e |
| 60 min | 1.14 ± 0.34 | 2.61 ± 0.19b | 2.65 ± 0.06d, e |
| 90 min | 1.26 ± 0.40 | 2.85 ± 0.22b | 2.79 ± 0.67d, e |
| 120 min | 1.36 ± 0.49 | 3.23 ± 0.19b | 3.20 ± 0.09d, e |
| TAS (Mean ± SD, μmol/L) | |||
| Baseline | 0.59 ± 0.11 | 0.47 ± 0.14a | 0.39 ± 0.08c, e |
| End of shock | 0.70 ± 0.12 | 0.80 ± 0.19a | 0.75 ± 0.13c, e |
| 30 min | 0.73 ± 0.11 | 0.86 ± 0.18a | 0.77 ± 0.09c, e |
| 60 min | 0.77 ± 0.10 | 0.75 ± 0.16a | 0.61 ± 0.13c, e |
| 90 min | 0.79 ± 0.11 | 0.59 ± 0.08b | 0.55 ± 0.10d, e |
| 120 min | 0.77 ± 0.08 | 0.49 ± 0.01b | 0.47 ± 0.08d, e |
| LPS (Median-range, EU/mL) | |||
| Baseline | 0.26 (0.05–0.56) | 0.39 (0.05–4.18)a | 0.05 (0.05–1.38)c, e |
| End of shock | 0.10 (0.05–0.13) | 0.57 (0.13–1.65)b | 0.05 (0.05–0.85)c, e |
| 30 min | 0.05 (0.05–0.17) | 0.32 (0.05–0.56)a | 0.05 (0.05–0.96)c, e |
| 60 min | 0.05 (0.05–0.48) | 0.24 (0.06–0.49)a | 0.14 (0.05–0.89)c, e |
| 90 min | 0.05 (0.05–0.54) | 0.60 (0.05–1.23)a | 0.05 (0.05–1.45)c, e |
| 120 min | 0.05 (0.05–0.46) | 0.42 (0.05–1.58)a | 0.05 (0.05–8.38)c, e |
Serum concentrations of malndialdehyde (MDA), total antioxidant status (TAS) and endotoxin (LPS) of animals undergoing sham operation (group sham); animals undergoing hemorrhagic shock to MAP 40 mmHg (group shock-40); and animals undergoing hemorrhagic shock to MAP 30 mmHg (group shock-30).
Statistical comparisons after Bonferroni correction
Group sham vs group shock-40: apNS (non-significant); bp < 0.05
Group sham vs group shock-30: cpNS (non-significant); dp < 0.05
Group shock-40 vs group shock-30: epNS (non-significant); fp < 0.05